This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.
申请公布号
SG176829(A1)
申请公布日期
2012.01.30
申请号
SG20110092319
申请日期
2010.06.24
申请人
GLAXOSMITHKLINE BIOLOGICALS S.A.;ID BIOMEDICAL CORPORATION OF QUEBEC
发明人
BAUDOUX, GUY JEAN MARIE FERNAND PIERRE;BLAIS, NORMAND;CYR, SONYA L;RHEAULT, PATRICK;RUELLE, JEAN LOUIS
